Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid to prevent surgery in chronic subdural hematoma
NL-OMON54811Phase 3Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in Chronic subdural haematoma (CSDH), sponsored by Amsterdam University Medical Center. Started Jun 2018; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on NL-OMON54811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54811.